Anti-ganglioside GM2 monoclonal antibody-dependent killing of human lung cancer cells by lymphocytes and monocytes

Japanese Journal of Cancer Research : Gann
M HanibuchiS Sone

Abstract

Ganglioside GM2 (GM2) frequently appears on the cell surface of human cancers of neuroendocrine origin. A mouse-human chimeric monoclonal antibody (mAb), KM966, against GM2 was previously found to promote the lysis of various cancer cells by human blood mononuclear cells (MNC). In this study, we analyzed the effector cells responsible for the chimeric mAb-dependent cell-mediated cytotoxicity (ADCC) against small cell lung cancer (SCLC) cells and examined the enhancing effect of various cytokines on the ADCC activity. The ADCC activity was assessed by 4-h 51Cr release assay. Highly purified lymphocytes (> 99%) and monocytes (> 90%) were separated by centrifugal elutriation from peripheral blood MNC of the same healthy donor. KM966 induced lysis of SCLC cells mediated by both lymphocytes and monocytes to similar extents, in a dose-dependent manner. Pretreatment of lymphocytes with various cytokines [interleukin (IL)-2, IL-12 and interferon-gamma] and that of monocytes with macrophage-colony-stimulating factor significantly augmented the killer activity against SCLC cells in the presence of KM966 mAb. KM966 was also effective for the lysis of non-small cell lung cancer cells in direct proportion to the GM2 expression levels. These...Continue Reading

References

Feb 15, 1979·European Journal of Biochemistry·J PortoukalianJ F Doré
Oct 21, 1992·International Journal of Cancer. Journal International Du Cancer·R OrlandiM I Colnaghi
Jun 15, 1991·Cancer·M H RavindranathR F Irie
Oct 1, 1988·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·S Vadhan-RajA N Houghton
Sep 15, 1988·International Journal of Cancer. Journal International Du Cancer·S SoneT Ogura
Sep 1, 1987·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·N K CheungN A Berger
Nov 1, 1993·World Journal of Surgery·M Crump

❮ Previous
Next ❯

Citations

Aug 19, 1999·Critical Reviews in Oncology/hematology·A ArdizzoniS Ferrini
Jun 6, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Wei WangSaburo Sone
Jul 27, 1999·International Journal of Cancer. Journal International Du Cancer·H FukumotoN Saijo

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenocortical Carcinoma

Adrenocortical carcinoma (ACC) is a rare malignancy of the adrenal cortex, associated with a generally dismal prognosis owing to its aggressive behavior. Here are the latest discoveries pertaining to this disease.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Antibody-Dependent Cell Cytotoxicity

Antibody-dependent cellular toxicity refers to the lysis of a target cell by a non-sensitized effector cell of the immune system as a result of antibodies binding to the target cell membrane and engaging the Fc receptors on the immune effector cells. Find the latest research on antibody-dependent cellular toxicity here.